"Pibao Pharmaceuticals" Got Listed in the Stock Market

On the morning of June 18, Guangdong Pibao Pharmaceuticals Joint-stock Company's A shares got listed in Shenzhen Stock Exchange successfully.
Pibao Pharmaceuticals is an excellent enterprise under Taiantang Group, being primarily engaged in research, production and sales of traditional Chinese medicines, holding the licenses for production of 108 varieties of 14 medicament forms, including unctions, pills and so on. So far, it has built up a perfect product system covering three major brands, namely, Pibao, Liren and Qilin. Among others, 3 varieties are nationally protected varieties, 6 are unique varieties of the country, and 49 have been listed into the OTC catalogue. In recent years, as a leading enterprise in the inland market of Chinese traditional medicines for skin diseases for exterior use, Pibao Pharmaceuticals continued to develop its advantageous products, took the road of combination of production, learning and research, set up the research center of dermic engineering technology of Chinese traditional medicines and post-doctor research station, took Chinese medicines for skin diseases and modern Chinese patent drugs as the research targets to further develop its characteristic products and made many technical breakthroughs. Thus, it has become an innovation platform of modern Chinese drugs and industrialization platform for technical fruits well-known in the country, and has been rated as a "National High and New Technology Enterprise".
It is reported that the number of A shares issued by the Company this time is 25,000,000 and the issued price per share is RMB29.82. The opening price on June 18 reached RMB33.20, and the closing price was RMB32.78, with a growth rate of 9.93 .

Source : Shantou Daily ,June 19,2010